Literature DB >> 6769270

A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test.

A R Genazzani, F Camanni, F Massara, E Picciolini, D Cocchi, L Belforte, E E Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6769270     DOI： 10.1530/acta.0.0930139

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  10 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Nomifensine in hyperprolactinemic states.

Authors:  E E Müller; F Camanni; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

4.  Nomifensine-induced pregnancy in a hyperprolactinemic woman.

Authors:  A R Genazzani; V De Leo; F Camanni; E E Müller
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

5.  Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.

Authors:  F Iannotta; P Fachinetti; A Fachinetti; G Pinotti; L Usellini
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

6.  Evaluation of hypothalamic dopaminergic function by neuropharmacologic means in aged women.

Authors:  D Cocchi; C Castoldi; S Locatelli; A Novelli; A M Colombo; A Tammaro; E E Müller
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  Pituitary secretion after administration of a new cerebroactive drug, fipexide.

Authors:  E Rolandi; R Franceschini; A Marabini; V Messina; P Bongera; T Barreca
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.

Authors:  F Minuto; A Barbarino; G Baviera; G Mazzocchi; L De Marinis; R Leonardi; D Bernasconi; E Menini; G Maira; C Anile
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

Review 9.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

10.  Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.

Authors:  M Giusti; G Mazzocchi; D Mignone; W Tarditi; G Giordano
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.